Companies: 10,795·Total market cap: $144.5T
ObsEva S.A.

ObsEva S.A.

OBSVNASDAQHealthcare
$0.10
+$0.00(+0.00%)
Market Cap$10996640
P/E Ratio
52W High$2.14
52W Low$0.065

ObsEva S.A. (OBSV) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

obsv · pe ratio · data through Dec 31, 2022

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for ObsEva S.A. (OBSV) measures how much investors pay for each dollar of the company's trailing earnings. OBSV's current PE ratio of N/A is calculated by dividing its stock price of $0.10 by its TTM earnings per share of -$0.32.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2022-12-31

Forward P/E
N/A
EPS (TTM)
-$0.32
TTM · diluted EPS
PEG Ratio
0.02
Below 1.0 · Growth adjusted
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · ObsEva S.A. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2014 – 2022 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Biotechnology · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
ObsEva S.A.
ObsEva S.A.You
OBSV
$11MN/A-$0.32
Applied Molecular Transport Inc.
Applied Molecular Transport Inc.
AMTI
$11MN/A-$3.23
Apexigen, Inc.
Apexigen, Inc.
APGN
$10MN/A-$1.59
Cyclacel Pharmaceuticals, Inc.
Cyclacel Pharmaceuticals, Inc.
CYCC
$11MN/A-$1.37
Gelesis Holdings, Inc.
Gelesis Holdings, Inc.
GLS
$12MN/A-$0.79
TuHURA Biosciences, Inc.
TuHURA Biosciences, Inc.
HURA
$130MN/A-$0.63
IMV Inc.
IMV Inc.
IMVIF
$0MN/A-$4.37

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 9 of 9 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2022-12-31Latest
FY2022
$-0.32
2021-12-31
FY2021
$-0.78
2020-12-31
FY2020
$-1.67
2019-12-31
FY2019
$-2.49
2018-12-31
FY2018
$-1.91
2017-12-31
FY2017
$-2.25
2016-12-31
FY2016
$-1.02
2015-12-31
FY2015
$-0.67
2014-12-31
FY2014
$-0.43

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for ObsEva S.A. (OBSV) measures how much investors pay for each dollar of the company's trailing earnings. OBSV's current PE ratio of N/A is calculated by dividing its stock price of $0.10 by its TTM earnings per share of -$0.32.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.10 ÷ -$0.32 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

OBSV pe ratio · 6 questions

OBSV's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.10 and TTM EPS of -$0.32. Data sourced from Financial Modeling Prep via OBSV's SEC 10-K and 10-Q filings.

OBSV PE ratioWhat is OBSV PE ratioCurrent PE ratio of OBSVOBSV PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · ObsEva S.A. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09